(1. 中国人民解放军总医院第一医学中心内分泌科,北京100853;2. 中国人民解放军总医院海南医院住院与病案管理科,海南 三亚 572000;3. 广西中医药大学附属瑞康医院内分泌科,南宁 530001;4. 中国人民解放军总医院第二医学中心老年医学科,北京100853)
海南省重点研发项目(ZDYF2018117); 三亚科技创新项目(2017YW16); 海南省卫计委课题(15A200071); 海南省重大科技计划项目(ZDKJ2016008)
(1. Department of Endocrinology, First Medical Center, Chinse PLA General Hospital, Beijing 100853, China;2. Inpatient and Medical Record Management Department, Hainan Hospital, Chinse PLA General Hospital, Sanya 572000, Hainan Province, China;3. Department of Endocrinology, Ruikang Hospital, Guangxi University of Traditional Chinese Medicine, Nanning 530001, China;4. Department of Geriatrics, Second Medical Center, Chinse PLA General Hospital, Beijing 100853, China)
This work was supported by Hainan Provincial Key Research and Development Project (ZDYF2018117), Sanya Science and TechnologyInnovation Project ( 2017YW16), Hainan Provincial Health and Family Planning Commission Project ( 15A200071), and HainanProvince Science and Technology Plan Major Project (ZDKJ2016008).
李慧琪,张赛春,王敏,单晨,雷永红,郭清华,母义明.互联网+移动医疗模式下服用恩格列净2型糖尿病患者管理[J].中华老年多器官疾病杂志,2022,21(1):6-10
DOI:10.11915/j. issn.1671-5403.2022.01.002
